
Supports COPD_REG

Supports DM034, DM035
Patients are on a non-statin lipid-lowering drug (e.g. ezetimibe), but have no PCA code recorded to explain why a statin isn’t being prescribed.
If a statin is declined, contraindicated, or not tolerated, add the appropriate PCA code to ensure QOF compliance.
Supports DM006.
Patients with diabetes and evidence of proteinuria or microalbuminuria who previously declined or were contraindicated for ACE inhibitors or ARBs within the last 3 years.
Review to see if a PCA can be reapplied this year, or if therapy should be reconsidered.
Supports CD001/CD002/DM020/DM021/DM034/DM036/HYP010/HYP011.
Patients whose most recent frailty diagnosis was mild (or none), and the most recent Rockwood score or assessment was at least 6. It is in the Practice’s interest to action patients listed here as they can be removed from the target requirements.
Add a diagnosis code 'Moderate frailty' or 'Severe frailty' to remove patient from QOF indicator (or move from DM020 to DM021).
Supports CD001/CD002/DM020/DM021/DM034/DM036/HYP010/HYP011.
Patients whose most recent frailty diagnosis was moderate or severe, but the most recent Rockwood score or assessment was less than 6. These patients would technically already be excluded from the affected indicators, but arguably the more recent Rockwood may suggest the patient is anything but frail. Use the report to review frailty and Rockwood coding, both in terms of dates and scores. Some frailty diagnoses may be many years ago while Rockwood is recent.
Add the diagnosis code 'Mild frailty' to reinstate patient to QOF indicator (or move from DM021 to DM020)

Supports HF006.
Patients with heart failure and LVSD who are not prescribed a beta-blocker, but had a PCA applied previously.
Reassess the patient’s current eligibility. If they remain unsuitable, reapply the PCA.
Supports HF009.
Patients with heart failure and LVSD were previously included in the HF2 register. A preserved or mildly reduced ejection fraction has been recorded, or an ejection fraction percentage has been documented which may indicate HFrEF.

Supports HF009.
Patients with heart failure and LVSD were previously included in the HF2 register. No ejection fraction has been recorded (ie: they only have a code for LVSD).

Supports HF009.
Patients with heart failure may not be correctly classified. Review diagnoses for evidence of LVSD or reduced ejection fractions.
Use the report QOF 2026-27 - Heart Failure to identify the earliest diagnosis dates to locate documents referencing ejection fractions or echos.

Supports HF006.
Patients with heart failure and LVSD who are not prescribed a beta-blocker, but had a PCA applied previously.
Reassess the patient’s current eligibility. If they remain unsuitable, reapply the PCA.
Supports HF006.
Heart failure patients with LVSD not on ACE inhibitors or ARBs due to previous decline, contraindication, or non-tolerance.
Review patient status. If still unsuitable, the PCA can be reapplied.
Supports NDH_REG.
Patients with a history of gestational diabetes who were not on the NDH register last year, but have been added to the new expanded register. The purpose of this report is to demonstrate the additional number of patients on the register.

Supports CHD015/016, DM036, HYP008/009, and STIA014/015.
Patients have had a home or ambulatory BP recorded that would meet the QOF target if it had been taken in surgery.
Invite for an in-practice BP check to secure QOF compliance for multiple indicators.
Also supports CHD, DM, Hypertension, and Stroke/TIA BP indicators.
Patients have no BP reading this year, but last year’s reading was within range.
These are ideal for opportunistic BP checks — one quick reading could achieve multiple QOF indicators.
Patient has 3 conditions of ASCVD, hypertension, type 2 diabetes, obstructive sleep apnoea, but most recent blood results suggestive of dyslipidaemia not during the contract year.
Issuing 1 course of lipid therapy in the second half of the contract year may be sufficient to make the patient eligible for OB005.

Patient has 3 conditions of ASCVD, type 2 diabetes, obstructive sleep apnoea, dyslipidaemia, and most recent blood pressure is suggestive of hypertension.
Use the output to review latest values then target patients. Repeating BMI and BP followed by a new diagnosis of hypertension may add patient to OBES2_REG, making the patient eligible for OB005.
Patient has 3 conditions of ASCVD, hypertension, obstructive sleep apnoea, dyslipidaemia, and most recent HbA1c is suggestive of type 2 diabetes.
Use the output to review latest values then target patients. Repeating BMI and HbA1c followed by a diagnosis of type 2 diabetes may add patient to OBES2_REG., making the patient eligible for OB005.